Synergistically Enhancing the Therapeutic Effect of Radiation Therapy with Radiation Activatable and Reactive Oxygen Species-Releasing Nanostructures
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Nanoparticle-based radio-sensitizers can amplify the effects of radiation therapy on tumor tissue even at relatively low concentrations while reducing the potential side effects to healthy surrounding tissues. In this study, we investigated a hybrid anisotropic nanostructure, composed of gold (Au) and titanium dioxide (TiO 2 ), as a radio-sensitizer for radiation therapy of triple-negative breast cancer (TNBC). In contrast to other gold-based radio sensitizers, dumbbell-like Au-TiO 2 nanoparticles (DATs) show a synergistic therapeutic effect on radiation therapy, mainly because of strong asymmetric electric coupling between the high atomic number metals and dielectric oxides at their interfaces. The generation of secondary electrons and reactive oxygen species (ROS) from DATs triggered by X-ray irradiation can significantly enhance the radiation effect. After endocytosed by cancer cells, DATs can generate a large amount of ROS under X-ray irradiation, eventually inducing cancer cell apoptosis. Significant tumor growth suppression and overall improvement in survival rate in a TNBC tumor model have been successfully demonstrated under DAT uptake for a radio-sensitized radiation therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Fate and Toxicity of Raman-Active Silica-Gold Nanoparticles in Mice
Thakor, A. S., Luong, R., Paulmurugan, R., Lin, F. I., Kempen, P., Zavaleta, C., Chu, P., Massoud, T. F., Sinclair, R., & Gambhir, S. S. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001963 · Cited by 159
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Versatile Types of Organic/Inorganic Nanohybrids: From Strategic Design to Biomedical Applications
Zhao, N., Yan, L., Zhao, X., Chen, X., Li, A., Zheng, D., Zhou, X., Dai, X., & Xu, F.-J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00401 · Cited by 429
X-ray-activated nanosystems for theranostic applications
Chen, X., Song, J., Chen, X., & Yang, H. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00921j · Cited by 401
Reactive Oxygen Species‐Regulating Strategies Based on Nanomaterials for Disease Treatment
Zhang, C., Wang, X., Du, J., Gu, Z., & Zhao, Y. (2021) · Advanced Science · doi:10.1002/advs.202002797 · Cited by 401
Lin, X., Liu, S., Zhang, X., Zhu, R., Chen, S., Chen, X., Song, J., & Yang, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201912768 · Cited by 335
Controlling the biodistribution and clearance of nanomedicines
Cabral, H., Li, J., Miyata, K., & Kataoka, K. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00138-1 · Cited by 303
“This strategy has been pursued clinically in patients with colorectal cancer after treatment with bevacizumab 229 and in patients with brain tumours treated with cediranib (AZD2171; a pan-VEGF receptor tyrosine kinase inhibitor) 230 or with cediranib plus temozolomide and X-rays 231–233 .”
InfluentialJanus Nanoparticles: From Fabrication to (Bio)Applications
Zhang, X., Fu, Q., Duan, H., Song, J., & Yang, H. (2021) · ACS Nano · doi:10.1021/acsnano.1c01146 · Cited by 286
Nano-ROS-generating approaches to cancer dynamic therapy: Lessons from nanoparticles
Zhang, Q., Luo, Q., Liu, Z., Sun, M., & Dong, X. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.141225 · Cited by 94
Choi, B. J., Jung, K. O., Graves, E. E., & Pratx, G. (2018) · Nanotechnology · doi:10.1088/1361-6528/aae272 · Cited by 57
Bilynsky, C., Millot, N., & Papa, A. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10256 · Cited by 52
“engineered dumbbelllike NPs made of gold and titanium dioxide NPs to achieve a synergistic radiosensitization effect in vitro using triple-negative breast cancer SUM159 cells.(125) Such technology translated with a significant therapeutic effect both on tumor growth and animal survival in SUM159 tumor-bearing mice.”
BackgroundMethodTalik Sisin, N. N., Abdul Razak, K., Zainal Abidin, S., Che Mat, N. F., Abdullah, R., Ab Rashid, R., Khairil Anuar, M. A., & Rahman, W. N. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s269214 · Cited by 36
Zhu, Z., Wu, M., Sun, J., Huangfu, Z., Yin, L., Yong, W., Sun, J., Wang, G., Meng, F., & Zhong, Z. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1995080 · Cited by 17
Metadata
- Authors
- Cheng, K., Sano, M., Jenkins, C. H., Zhang, G., Vernekohl, D., Zhao, W., Wei, C., Zhang, Y., Zhang, Z., Liu, Y., Cheng, Z., & Xing, L.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-04-24
- Volume
- 12
- Issue
- 5
- Pages
- 4946-4958
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2800898645
- Cited by
- 136
- References
- 1
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.